Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder

被引：54

作者：

Chaudhari K. ^{[1
]}

Khanzode S. ^{[1
,2
]}

Dakhale G. ^{[5
]}

Saoji A. ^{[3
]}

Sarode S. ^{[4
]}

机构：

[1] Department of Pharmacology, Government Medical College Nagpur

[2] Medicine, Government Medical College Nagpur

[3] Psychiatry, Government Medical College Nagpur

[4] Physiology, Government Medical College Nagpur

[5] Department of Pharmacology, Indira Gandhi Government Medical College, Nagpur, Maharashtra

来源：

Indian Journal of Clinical Biochemistry | 2010年 / 25卷 / 1期

关键词：

Citalopram; Fluoxetine; Hamilton Rating Scale for Depression score; Major depression; Selective Serotonin Re-Uptake Inhibitors; Uric acid;

D O I：

10.1007/s12291-010-0016-z

中图分类号：

学科分类号：

摘要：

Derangement of antioxidant levels in major depressive disorder had been correlated with oxidative damage. The effect of Selective Serotonin Re-Uptake Inhibitors on endogenous antioxidant uric acid levels in major depressive disorder has never been examined. This was a prospective; open labeled, parallel, 12 weeks study, in which serum uric acid levels and Hamilton Rating Scale for Depression score were estimated in age and sex matched thirty-six healthy and forty major depressive disorder subjects before and after fluoxetine and citalopram treatment. Significant decrease in serum uric acid (P<0.0001) was observed in newly diagnosed major depressive disorder subjects when compared to healthy subjects. The trend was reversed after 6 weeks more significantly after 12 weeks of treatment with improvement in Hamilton Rating Scale for Depression score. Also, Significant and negative correlation was found between Hamilton Rating Scale for Depression score and serum uric acid level (r= -0.864, P<0.001) after 12 weeks of treatment. Treatment with fluoxetine or citalopram reverses endogenous antioxidants like uric acid and improves Hamilton Rating Scale for Depression score in major depressive disorder.

引用

页码：77 / 81

页数：4

共 20 条

[1] (2001)
[2] Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., Palsodkar R., Oxidative damage and major depression: The potential antioxidant action of selective serotonin re-uptake inhibitors, Redox Report, 8, 6, pp. 365-370, (2003)
[3] Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O., Antioxidative enzyme activities and lipid peroxidation in major depression: Alteration by antidepressant treatments, J. Affect. Dis., 64, pp. 43-51, (2001)
[4] Sapolsky R.M., The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death, Biol. Psychiatry, 48, pp. 755-765, (2000)
[5] Ozcan M.E., Gulec M., Ozerol E., Polat R., Akyol O., Antioxidant enzyme activities and oxidative stress in affective disorders, Int. Clin. Psychopharmacol, 19, 2, pp. 89-95, (2004)
[6] Sen C.K., Oxygen toxicity and antioxidants: State of the art, Ind. J. Physiol. Pharmacol., 39, 3, pp. 177-196, (1995)
[7] Singh R.P., Sharad S., Kapur S., Free radicals and oxidative stress in neurodegenerative diseases: Relevance of dietary antioxidants, JIACM, 5, 3, pp. 218-225, (2004)
[8] Kane P., Understanding the biochemical and biobehavioral nexus of depression, Nutritonal Research 1997 Explore Issue, 8, 1, (2005)
[9] Maes M., Wauters A., Neels H., Scharpe S., Gastel A.V., D'Hondt P., Et al., Total serum protein and serum protein fractions in depression: Relationship to depressive symptoms and glucocorticoid activity, J. Affect. Dis., 34, pp. 61-69, (1995)
[10] Yanik E., Erel O., Kati M., The relationship between potency of oxidative stress and severity of depression, Acta Neuropsychiatrica, 16, pp. 200-203, (2004)

← 1 2 →